This symposium brings together renowned experts, Professor Vinay Prasad from San Francisco, CA, USA, and Professor Alfredo Addeo from Geneva, Switzerland, who will share their expertise through captivating talks. Professor Prasad's presentation will delve into the meticulous evaluation of current evidence in the field. Professor Addeo's talk will focus on the specific utilization of evidence-based strategies in lung cancer treatment. We anticipate thought-provoking discussions to emerge during the panel discussion, moderated by Marco Donia.
By attending this symposium, healthcare professionals, researchers, and clinicians will gain valuable insights into overcoming the limitations faced in evidence-based medicine within the context of cancer immunotherapy. Engage in stimulating conversations, expand your understanding of clinical applications and treatment strategies, and discover collaborative opportunities to advance this transformative field.
The symposium aims to enhance our approach to evidence-based clinical cancer immunotherapy.
Target audience: cancer researchers (PhD students or higher) and professionals working in cancer drug development, prescription or reimbursement.
About the Keynote Speakers
Vinay Prasad is Professor of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF), CA, USA.
Renowned for his expertise in clinical cancer immunotherapy, evidence-based medicine, and healthcare policy, Professor Prasad has made significant contributions to the field through outstanding scientific publications and extensive editorial activity in leading oncology journals, along with his critical communication of research results to the public through modern channels such as social media, podcasts, books and Youtube videos. Professor Prasad's work encompasses critical evaluation of medical evidence, insightful research, and a steadfast dedication to improving patient care. As a speaker at the symposium, his profound knowledge and extensive experience will greatly enrich discussions on evidence-based clinical cancer immunotherapy, and play a pivotal role in shaping the future of the field.
Alfredo Addeo is Professor of Oncology and Head of Oncology Service at the Geneva University Hospital (HUG), Switzerland.
Professor Addeo specializes in evidence-based approaches in the treatment of cancer, with a particular focus on lung cancer immunotherapy. Through his extensive clinical research, which is evident in over 100 publications in international peer-reviewed journals and editorial contributions, Professor Addeo has made outstanding contributions to the field of lung cancer research. His unwavering commitment to improving patient outcomes is reflected in his work, which emphasizes the application of evidence-based strategies to optimize cancer treatment and enhance patient care. With his deep knowledge and valuable insights, Professor Addeo enriches the symposium by providing a comprehensive perspective on evidence-based lung cancer immunotherapy.